VYVGART was well-tolerated with a safety profile consistent with the established profile of VYVGART in patients with AChR-Ab seropositive gMG and other indications. No new safety concerns were ...
Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...
Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...
Dr Babak Ashrafi, a member of Superdrug’s Online Doctor team, explained: “Shingles can come as a shock, many people wake up ...
Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...
A red, itchy rash spread across the man's arms and chest, then worsened into erythroderma, a severe, widespread skin ...
The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback